ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.18, sa.5, ss.334-339, 2017 (SCI-Expanded)
Objective: Discontinuation of metformin treatment in patients scheduled for elective coronary angiography (CAG) is controversial because of post-procedural risks including acute contrast-induced nephropathy (CIN) and lactic acidosis (LA). This study aims to discuss the safety of continuing metformin treatment in patients undergoing elective CAG with normal or mildly impaired renal functions.